Page 44

Abril 2016

ARTÍCULOS DE INVESTIGACIÓN we learned? Int J Stroke 2009; 4 (5): 354-64. Trombolisis en accidente vascular isquémico - C. Guevara et al 15. Dzialowski I, Hill MD, Coutts SB, et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis, prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke 2006; 37 (4): 973-8. 16. Instituto de Salud Publica de Chile. Folleto al profesional. 450 Ref.:MT10692/09-http://www.ispch.cl/sites/default/ files/u7/B-936-05.pdf 17. Matute MC, Masjuan J, Egido JA, Fuentes B, Simal P, Díaz-Otero F, et al. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants. Cerebrovasc Dis 2012; 33 (3): 231-9. 18. Takayanagi S, Ochi T, Hanakita S, Suzuki Y, Maeda K. The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era. Neurol Med Chir (Tokyo) 2014; 54 (6): 435-40. Epub 2014 Mar 27. 19. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (London, England) 1991; 337 (8756): 1521-6. 20. Fiorelli M, Bastianello S, Von Kummer R, Del Zoppo G, Larrue V, Lesaffre E, et al; for the ECASS I Study Group. Hemorrhagic transformation within 36 hours of a cerebral infarct. Relationship with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30: 2280-4. 21. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scott Med J 1957; 2: 200-15. 22. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 2007; 38 (3): 1091-6. 23. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24 (1): 35-41. 24. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. The Lancet 2007; 369 (9558): 275- 82. 25. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. The Lancet 2012; 379 (9834): 2364-72. 26. Lavados PM, Sacks C, Prina L, Escobar A, Tossi C, Araya F, et al. Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-year community-based prospective study (PISCIS project). The Lancet 365 (9478): 2206-15. 27. Fang J, Kapral MK, Richards J, Robertson A, Stamplecoski M, Silver FL. The Registry of Canadian Stroke Network: an evolving methodology. Acta neurologica Taiwanica 2011; 20 (2): 77-84. 28. Etgen T, Freudenberger T, Schwahn M, Rieder G, Sander D. Multimodal strategy in the successful implementation of a stroke unit in a community hospital. Acta neurologica Scandinavica 2011; 123 (6): 390-5. 29. Krebes S, Ebinger M, Baumann AM, Kellner PA, Rozanski M, Doepp F, et al. Development and validation of a dispatcher identification algorithm for stroke emergencies. Stroke 2012; 43 (3): 776-81. 30. Chong C, Chiang M, Chiu L. Revisiting unfractionated heparin as a contraindication to acute stroke intravenous thrombolysis. Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis. 2011; 22 (3): 240-1. 31. Ducas J, Chan MC, Miller A, Kashour T. Immediate protamine administration and sheath removal following percutaneous coronary intervention: a prospective study of 429 patients. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions 2002; 56 (2): 196-9. 32. Diener HC, Foerch C, Riess H, Röther J, Schroth G, Weber R. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment. Lancet Neurol 2013; 12 (7): 677-88. 33. Brunner F, Tomandl B, Schröter A, Mellinghoff C, Haldenwanger A, Hildebrandt H, et al. Hemorrhagic complications after systemic thrombolysis in acute stroke patients with abnormal baseline coagulation. European Journal of Neurology 2011; 18 (12): 1407-11. 34. Safouris A, Massaut J, Triantafyllou N, Gazagnes MD, Tsivgoulis G. Safety of IV thrombolysis in an acute stroke patient anticoagulated with unfractioned heparin. J Neurol 2013; 260 (11): 2911-2. 35. Lavados PM, Hoppe WA. Unidades de tratamiento del ataque cerebrovascular (UTAC) en Chile. Rev Med Chile 2005; 133: 1271-3. Rev Med Chile 2016; 144: 442-450


Abril 2016
To see the actual publication please follow the link above